| 1 |
34923994 | Rationale and design of the multicentric, double-blind, double-placebo, randomized trial APrepitant versus HYdroxyzine in association with cytoreductive treatments for patients with myeloproliferative neoplasia suffering from Persistent Aquagenic Pruritus. Trial acronym: APHYPAP. | 2021 Dec 19 |
1 |
| 2 |
24900720 | Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors. | 2013 Jul 11 |
1 |
| 3 |
22570081 | Molecular interactions of c-ABL mutants in complex with imatinib/nilotinib: a computational study using linear interaction energy (LIE) calculations. | 2012 Sep |
2 |
| 4 |
19906645 | Role of interfacial water molecules in proline-rich ligand recognition by the Src homology 3 domain of Abl. | 2010 Jan 22 |
1 |
| 5 |
20149665 | Design, synthesis, and biological evaluation of novel water-soluble triptolide derivatives: Antineoplastic activity against imatinib-resistant CML cells bearing T315I mutant Bcr-Abl. | 2010 Mar 1 |
1 |
| 6 |
20183853 | Understanding kinase selectivity through energetic analysis of binding site waters. | 2010 Apr 6 |
1 |
| 7 |
20970221 | 2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors. | 2010 Dec |
1 |
| 8 |
17407569 | The high-resolution NMR structure of the R21A Spc-SH3:P41 complex: understanding the determinants of binding affinity by comparison with Abl-SH3. | 2007 Apr 2 |
1 |
| 9 |
15890005 | Controlled elimination of intracellular H(2)O(2): regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. | 2005 May-Jun |
1 |